Navellier & Associates Inc Abbott Laboratories Transaction History
Navellier & Associates Inc
- $792 Million
- Q4 2024
A detailed history of Navellier & Associates Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Navellier & Associates Inc holds 5,587 shares of ABT stock, worth $721,114. This represents 0.08% of its overall portfolio holdings.
Number of Shares
5,587
Previous 6,860
18.56%
Holding current value
$721,114
Previous $782,000
19.31%
% of portfolio
0.08%
Previous 0.11%
Shares
4 transactions
Others Institutions Holding ABT
# of Institutions
3,247Shares Held
1.31BCall Options Held
8.71MPut Options Held
8.02M-
Vanguard Group Inc Valley Forge, PA168MShares$21.7 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$9.9 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$8.49 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.88 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $226B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...